
    
      This is an open randomized controlled trial with 3 groups testing smokeless tobacco in
      smoking cessation: 200 smokers will get smokeless tobacco for 3 months, 200 will get nicotine
      buccal tablets for 3 months and 200 will get 7-mg nicotine patches for 3 months (control
      arm). After ½, 1 and 1½ a year failures will get smokeless tobacco in the first 2 groups,
      while only 7 mg nicotine patches in control group until 1½ year where failures in this group
      also will get smokeless tobacco. Every ½ year cholesterol, blood pressure, lung function and
      BMI will be assessed and used to enhance adherence of the participants in this trial.
    
  